Ravi Salgia to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Ravi Salgia has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.107
-
Evidence-based role of bevacizumab in non-small cell lung cancer. Ann Oncol. 2013 Jan; 24(1):6-9.
Score: 0.107
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.